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Background
Clostridium difficile infection (CDI) is an increasingly
common hospital-associated infection. There is an increas-
ing awareness in recent years about the impact of commu-
nity-acquired Clostridium difficile infection (CA-CDI).
Methods
We enrolled all CDI patients admitted to the Adults
III department of the National Institute for Infectious Dis-
eases “Prof. Dr. Matei Balş”, Bucharest, between January –
July 2014. Stool culture, toxin EIA and Cepheid Gene
Xpert C. difficile test were used for CDI diagnosis. The
subjects were divided into two groups: CA-CDI patients
(Group 1) and HA-CDI patients (Group 2). Our objective
was to describe the clinical, epidemiologic features and
outcome of CA-CDI compared to hospital-associated
CDIs (HA-CDI) including the ATLAS bedside severity
scoring system. Statistical analyses were performed using
SPSS Statistics package v.17.
Results
We included 57 patients with median age 69 years
(IQR=54;78). Male/female ratio was 0.72. Most patients
(75.4%) presented with an initial CDI episode, the rest hav-
ing the first (17.5%) or next (2-5) (7%) recurrences. The
median value of ATLAS score was 3 (IQR=2;4). Most
patients (87.7%) had previously received antibiotic therapy.
In 15.8% cases cancer had been previously diagnosed and
17.5% of patients had had recent surgery. Clostridium
difficile 027 strain was identified in almost all patients.
The patients were treated with vancomycin (73.7%),
metronidazole (12.3%), vancomycin/metronidazole asso-
ciation (10.3%); 3.5% received tigecycline. Nine patients
(15.8%) were included in the CA-CDI and forty-eight
patients (84.2%) had HA-CDI. The number of CA-CDI
in the first 7 months of 2014 was about two times
higher than in 2013. Group 1 had fewer comorbidities,
were younger (median 52 years (IQR 34.5;77) vs. 69.50
years (IQR 55.25;78), p=0.164, had more mild CDI epi-
sode (55.6% vs. 33.3%, p=0.26), all had received antibio-
tics and two cases received proton pomp inhibitors.
Group 1 received more aminopenicillins (33.3%) and
less CEPH (11.1%) compared to Group 2 (2.1% and
18.8%, respectively, p=0.06 and p=1). FQ use was similar:
22.2% in Group 1 vs. 18.8% in Group 2. There was one
death in HA-CDI. There were no statistical differences
between the two groups regarding: sex distribution, med-
ian ATLAS score – 3, rates of complicated/recurrent
CDI and use of vancomycin or metronidazole treatment.
Conclusion
Approximately one sixth of CDIs were CA-CDI. These
patients were younger, had predominant mild CDI and
received more frequently aminopenicillins than those
with HA-CDI. We found no significant differences
between the two groups regarding Clostridium difficile
027 strain prevalence and infection severity.
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